Novabay
Beauty, Biotechnology, Cosmetics
Novabay is one of the largest premium sodium bicarbonate producers in the Asia-Pacific region, excluding China. It supplies high-value grades for pharmaceutical, personal care, and food applications. The company is certified with key cGMP and API standards and operates a fully automated facility. Novabay has a current production capacity of approximately 60,000 tonnes.
Key facts
- Employees
- 66
- Industries
- Beauty, Biotechnology, Cosmetics
- Status
- Public (SDEV)
- Website
- novabay.com
- Company page
Recent activity at Novabay
- : SEC 8-K (8.01):
- : SEC 8-K (8.01): On September 29, 2026, Stablecoin Development Corporation reported unusual trading activity in its common stock on the NYSE American. In response to this activity, the Company indicated that it had made inquiries and found no reason for corrective actions, asserting that there were no material non-public information or pending transactions that could explain the market fluctuations. This announcement serves to reassure investors that there have been no undisclosed developments affecting the Company's business.
- : SEC 8-K (5.02): On September 2, 2026, Stablecoin Development Corporation appointed David Garcia Rios as a Class II director on its Board of Directors. His term as a director is set to expire at the company's 2027 annual meeting of stockholders. At this time, Mr. Garcia Rios will not serve on any board committees, indicating a potential future governance structure change. This appointment aligns with the company’s strategic evolution and governance structure enhancements.
- : SEC 8-K (7.01): On July 31, 2026, Stablecoin Development Corporation issued a press release regarding its results of operations for the quarter ended June 30, 2026. The press release highlights the Company's engagement in SKY-related on-chain activities, including staking, and indicates that it holds approximately 2.30 billion SKY tokens as of July 27, 2026. This information was disclosed under Regulation FD as the Company seeks to keep investors informed about its financial position and staking rewards, reflecting ongoing strategic developments in its cryptocurrency operations.
- : SEC 8-K (5.02): On July 15, 2026, Stablecoin Development Corporation appointed Henry Blynn as Chief Operating Officer. Mr. Blynn has significant experience, having served as Head of Business Operations and Strategy since March 2026, and he brings a background from firms like R01 Fund LP and FalconX. To formalize this appointment, an amended and restated employment agreement was executed on July 16, 2026, granting him a Base Salary of $300,000 and a potential bonus of 50% of his salary based on performance. Notably, the agreement includes severance benefits if employment is terminated without cause or if he resigns for good reason, reflecting the company's commitment to executive retention and performance-based compensation.
- : SEC 8-K (1.01): On June 12, 2026, Stablecoin Development Corporation entered into an amendment with R01 Fund LP to modify the October 2025 Pre-Funded Warrants by removing certain exercisability restrictions. Following this, on June 15, 2026, Framework Ventures IV L.P. also amended their warrants and fully exercised them on a cashless basis, resulting in a total issuance of 22,614,600 shares of the Company's common stock. This transaction significantly increases the total shares outstanding, which reached 50,449,780 shares as of June 15, 2026, potentially impacting ownership and control dynamics within the Company. The Amendment No. 1 to the Pre-Funded Warrant addresses these adjustments as detailed in the attached Exhibit 4.1.
- : SEC 8-K (7.01): On May 20, 2026, the Company, Stablecoin Development Corporation, issued a press release regarding its operational results for the quarter ending March 31, 2026. The announcement highlighted updates on the Company's holdings in SKY tokens, now totaling approximately 2.26 billion as of May 14, 2026, as well as its staking activities related to these tokens. This disclosure is significant for shareholders as it outlines the Company’s financial performance and strategic positioning in the SKY token market. The details of the press release are included as Exhibit 99.1, which is furnished but not filed for liability purposes under the Securities Act or the Exchange Act.
- : SEC 8-K (2.02): On May 20, 2026, Stablecoin Development Corporation announced its financial results for the quarter ended March 31, 2026. This announcement also included updates on the company's SKY holdings and accumulated staking rewards, providing key financial insights and performance metrics essential for investors. The press release serves to inform the market about the company's current financial standing and operational performance, thereby facilitating transparency and compliance with SEC regulations. The filing highlights the company's proactive communication with shareholders and the market regarding its financial health and strategic positioning in the evolving digital asset landscape.
- : SEC 8-K (4.02): On April 27, 2026, the audit committee of the Company concluded that the previously issued audited consolidated financial statements for the year ended December 31, 2025, should no longer be relied upon due to an error related to outstanding pre-funded warrants. The error involved anti-dilution adjustments impacting the number of shares issuable; initially, the warrants were for 1,081,082 shares but increased to 22,664,040 shares, resulting in a substantial increase in warrant liability from $30.4 million to $639.1 million. This also affected the net loss reported for 2025, which adjusted from $22.1 million to $630.8 million. The Company plans to correct these errors in a Form 10-K/A, although the adjustments are non-cash and don't impact cash flows or operations.
- : SEC 8-K (5.02): On March 31, 2026, NovaBay Pharmaceuticals, Inc. approved significant equity awards under the newly adopted 2026 Equity Incentive Plan. The plan allows grants of various stock-based rewards to executives and employees, including 22,223,927 shares for the Initial Share Pool, with additional shares available through annual increases. Michael Kazley received 4,118,828 restricted stock units (RSUs) and 15,445,603 performance-based restricted stock units (PSUs), aligning his compensation with long-term shareholder value. Tommy Law was granted 300,000 RSUs. Kazley's RSUs will fully vest on February 16, 2027, while Law’s will vest over three years, marking a strategic shift in compensation tied closely to performance metrics. This plan addresses significant governance implications by linking executive compensation more directly to company performance outcomes.
Novabay funding history
| Date | Round | Amount |
|---|---|---|
| Jan 2026 | Venture | $134.0M |
| Jun 2024 | Venture | $226K |
| Apr 2024 | Seed | $665K |
| Jan 2024 | Seed | $555K |
| May 2023 | Seed | $3.0M |
Leadership
- PAUL FREIMAN, Director
- MIJIA WU, Director
- XINZHOU LI, Director
- YENYOU ZHENG, Director
- XIAOPEI WANG, Director
- SWAN SIT, Director
- PAUL FREIMAN, Director
- MIJIA WU, Director
- XINZHOU LI, Director
- YENYOU ZHENG, Director
- XIAOPEI WANG, Director
- SWAN SIT, Director
Verified email and direct lines for Novabay’s decision-makers are on Fundz. See plans — or book a 15-minute walkthrough.
Novabay in the news
- NovaBay Pharmaceutical (NBY) pivoting to crypto - CoinDesk (Mar 23, 2026)
- NovaBay Pharmaceuticals Inc. announces the launch of Avenova Eye Health Support oral supplement - Ophthalmology Times (Mar 08, 2023)
- Katabatic Winds Rake Terra Nova Bay - NASA Science (.gov) (Dec 02, 2025)
- High Salinity Shelf Water production rates in Terra Nova Bay, Ross Sea from high-resolution salinity observations - Nature (Jan 16, 2024)
- NovaBay’s Rise: Future Growth or Bubble? - StocksToTrade (Aug 20, 2025)
- SDEV: Abbott Cooper PLLC Announces Investigation on Behalf - GlobeNewswire (Aug 03, 2026)
- Seasonal Dynamics of Dissolved Iron on the Antarctic Continental Shelf: Late-Fall Observations From the Terra Nova Bay and Ross Ice Shelf Polynyas - AGU Publications (Oct 05, 2022)
- Combating antibiotic resistance: an interview with Ron Najafi, CEO NovaBay Pharmaceuticals - News-Medical (Aug 02, 2013)
Companies similar to Novabay
- Dr. Idriss · Beauty, Biotechnology, Cosmetics, Health Care, Manufacturing
- Labskin · Beauty, Biotechnology, Cosmetics, Fashion, Health Care
- SEEN · Beauty, Cosmetics, Fashion, Health Care, Manufacturing
- Maypharm Ltd · Beauty, Biotechnology, Cosmetics, Health Care, Manufacturing
- PMGC Holdings · Beauty, Biotechnology, Cosmetics, Fashion, Health Care
About Novabay: questions and answers
What does Novabay do?
Novabay is one of the largest premium sodium bicarbonate producers in the Asia-Pacific region, excluding China. It supplies high-value grades for pharmaceutical, personal care, and food applications. The company is certified with key cGMP and API standards and operates a fully automated facility. Novabay has a current production capacity of approximately 60,000 tonnes.
How many employees does Novabay have?
Novabay has about 66 employees.
Has Novabay raised funding?
Yes. Fundz has recorded 5 funding events for Novabay. The most recent, $134.0M, was in Jan 2026.
What is the latest news on Novabay?
On Oct 05, 2026, SEC 8-K (8.01):
Is Novabay a public company?
Yes. Novabay is publicly traded under the ticker SDEV.
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy